Genentech/Alkermes Discontinue Nutropin Depot; Commercial Reasons Cited
This article was originally published in The Pink Sheet Daily
Executive Summary
The original form of somatropin, as well as other Nutropin delivery systems, will continue to be available. Nutropin Depot represents less than 5% of Genentech's growth hormone sales. Company is also in the midst of discontinuing Protropin.
You may also be interested in...
Genentech Will Develop Long-Acting Growth Hormone Under Licensing Deal With Altus
The growth hormone candidate offers once-weekly dosing for adults and children.
Pazdur’s Big Moment: ‘Project Odyssey’ Webinar Gives Oncology Chief External Buy-In On His Ideas To Revamp ODAC
OCE Director Richard Pazdur is known for cultivating 'Pazdur moments' during advisory committees when he feels the conversation has gone off track. A recent webinar with ODAC members created a perfect opportunity to promote his agenda.